Medical Care
Global Nuclear Pharmacy Market Research Report 2025
- Mar 13, 25
- ID: 130808
- Pages: 79
- Figures: 71
- Views: 48
The global market for Nuclear Pharmacy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Nuclear Pharmacy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Pharmacy.
The Nuclear Pharmacy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nuclear Pharmacy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nuclear Pharmacy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
PharmaLogic
Nihon Medi-Physics
Yantai Dongcheng Biochemicals
Curium Pharma
Cardinal Health
Jubilant Radiopharma
GE Healthcare
UPPI
Segment by Type
Diagnostic Products
Therapeutic Products
Segment by Application
Pharmaceutical
Hospital
Laboratory
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nuclear Pharmacy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Nuclear Pharmacy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Pharmacy.
The Nuclear Pharmacy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nuclear Pharmacy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nuclear Pharmacy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
PharmaLogic
Nihon Medi-Physics
Yantai Dongcheng Biochemicals
Curium Pharma
Cardinal Health
Jubilant Radiopharma
GE Healthcare
UPPI
Segment by Type
Diagnostic Products
Therapeutic Products
Segment by Application
Pharmaceutical
Hospital
Laboratory
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nuclear Pharmacy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nuclear Pharmacy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Diagnostic Products
1.2.3 Therapeutic Products
1.3 Market by Application
1.3.1 Global Nuclear Pharmacy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical
1.3.3 Hospital
1.3.4 Laboratory
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nuclear Pharmacy Market Perspective (2020-2031)
2.2 Global Nuclear Pharmacy Growth Trends by Region
2.2.1 Global Nuclear Pharmacy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Nuclear Pharmacy Historic Market Size by Region (2020-2025)
2.2.3 Nuclear Pharmacy Forecasted Market Size by Region (2026-2031)
2.3 Nuclear Pharmacy Market Dynamics
2.3.1 Nuclear Pharmacy Industry Trends
2.3.2 Nuclear Pharmacy Market Drivers
2.3.3 Nuclear Pharmacy Market Challenges
2.3.4 Nuclear Pharmacy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nuclear Pharmacy Players by Revenue
3.1.1 Global Top Nuclear Pharmacy Players by Revenue (2020-2025)
3.1.2 Global Nuclear Pharmacy Revenue Market Share by Players (2020-2025)
3.2 Global Nuclear Pharmacy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Nuclear Pharmacy Revenue
3.4 Global Nuclear Pharmacy Market Concentration Ratio
3.4.1 Global Nuclear Pharmacy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nuclear Pharmacy Revenue in 2024
3.5 Global Key Players of Nuclear Pharmacy Head office and Area Served
3.6 Global Key Players of Nuclear Pharmacy, Product and Application
3.7 Global Key Players of Nuclear Pharmacy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Nuclear Pharmacy Breakdown Data by Type
4.1 Global Nuclear Pharmacy Historic Market Size by Type (2020-2025)
4.2 Global Nuclear Pharmacy Forecasted Market Size by Type (2026-2031)
5 Nuclear Pharmacy Breakdown Data by Application
5.1 Global Nuclear Pharmacy Historic Market Size by Application (2020-2025)
5.2 Global Nuclear Pharmacy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Nuclear Pharmacy Market Size (2020-2031)
6.2 North America Nuclear Pharmacy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Nuclear Pharmacy Market Size by Country (2020-2025)
6.4 North America Nuclear Pharmacy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nuclear Pharmacy Market Size (2020-2031)
7.2 Europe Nuclear Pharmacy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Nuclear Pharmacy Market Size by Country (2020-2025)
7.4 Europe Nuclear Pharmacy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nuclear Pharmacy Market Size (2020-2031)
8.2 Asia-Pacific Nuclear Pharmacy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Nuclear Pharmacy Market Size by Region (2020-2025)
8.4 Asia-Pacific Nuclear Pharmacy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nuclear Pharmacy Market Size (2020-2031)
9.2 Latin America Nuclear Pharmacy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Nuclear Pharmacy Market Size by Country (2020-2025)
9.4 Latin America Nuclear Pharmacy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nuclear Pharmacy Market Size (2020-2031)
10.2 Middle East & Africa Nuclear Pharmacy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Nuclear Pharmacy Market Size by Country (2020-2025)
10.4 Middle East & Africa Nuclear Pharmacy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 PharmaLogic
11.1.1 PharmaLogic Company Details
11.1.2 PharmaLogic Business Overview
11.1.3 PharmaLogic Nuclear Pharmacy Introduction
11.1.4 PharmaLogic Revenue in Nuclear Pharmacy Business (2020-2025)
11.1.5 PharmaLogic Recent Development
11.2 Nihon Medi-Physics
11.2.1 Nihon Medi-Physics Company Details
11.2.2 Nihon Medi-Physics Business Overview
11.2.3 Nihon Medi-Physics Nuclear Pharmacy Introduction
11.2.4 Nihon Medi-Physics Revenue in Nuclear Pharmacy Business (2020-2025)
11.2.5 Nihon Medi-Physics Recent Development
11.3 Yantai Dongcheng Biochemicals
11.3.1 Yantai Dongcheng Biochemicals Company Details
11.3.2 Yantai Dongcheng Biochemicals Business Overview
11.3.3 Yantai Dongcheng Biochemicals Nuclear Pharmacy Introduction
11.3.4 Yantai Dongcheng Biochemicals Revenue in Nuclear Pharmacy Business (2020-2025)
11.3.5 Yantai Dongcheng Biochemicals Recent Development
11.4 Curium Pharma
11.4.1 Curium Pharma Company Details
11.4.2 Curium Pharma Business Overview
11.4.3 Curium Pharma Nuclear Pharmacy Introduction
11.4.4 Curium Pharma Revenue in Nuclear Pharmacy Business (2020-2025)
11.4.5 Curium Pharma Recent Development
11.5 Cardinal Health
11.5.1 Cardinal Health Company Details
11.5.2 Cardinal Health Business Overview
11.5.3 Cardinal Health Nuclear Pharmacy Introduction
11.5.4 Cardinal Health Revenue in Nuclear Pharmacy Business (2020-2025)
11.5.5 Cardinal Health Recent Development
11.6 Jubilant Radiopharma
11.6.1 Jubilant Radiopharma Company Details
11.6.2 Jubilant Radiopharma Business Overview
11.6.3 Jubilant Radiopharma Nuclear Pharmacy Introduction
11.6.4 Jubilant Radiopharma Revenue in Nuclear Pharmacy Business (2020-2025)
11.6.5 Jubilant Radiopharma Recent Development
11.7 GE Healthcare
11.7.1 GE Healthcare Company Details
11.7.2 GE Healthcare Business Overview
11.7.3 GE Healthcare Nuclear Pharmacy Introduction
11.7.4 GE Healthcare Revenue in Nuclear Pharmacy Business (2020-2025)
11.7.5 GE Healthcare Recent Development
11.8 UPPI
11.8.1 UPPI Company Details
11.8.2 UPPI Business Overview
11.8.3 UPPI Nuclear Pharmacy Introduction
11.8.4 UPPI Revenue in Nuclear Pharmacy Business (2020-2025)
11.8.5 UPPI Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nuclear Pharmacy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Diagnostic Products
1.2.3 Therapeutic Products
1.3 Market by Application
1.3.1 Global Nuclear Pharmacy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical
1.3.3 Hospital
1.3.4 Laboratory
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nuclear Pharmacy Market Perspective (2020-2031)
2.2 Global Nuclear Pharmacy Growth Trends by Region
2.2.1 Global Nuclear Pharmacy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Nuclear Pharmacy Historic Market Size by Region (2020-2025)
2.2.3 Nuclear Pharmacy Forecasted Market Size by Region (2026-2031)
2.3 Nuclear Pharmacy Market Dynamics
2.3.1 Nuclear Pharmacy Industry Trends
2.3.2 Nuclear Pharmacy Market Drivers
2.3.3 Nuclear Pharmacy Market Challenges
2.3.4 Nuclear Pharmacy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nuclear Pharmacy Players by Revenue
3.1.1 Global Top Nuclear Pharmacy Players by Revenue (2020-2025)
3.1.2 Global Nuclear Pharmacy Revenue Market Share by Players (2020-2025)
3.2 Global Nuclear Pharmacy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Nuclear Pharmacy Revenue
3.4 Global Nuclear Pharmacy Market Concentration Ratio
3.4.1 Global Nuclear Pharmacy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nuclear Pharmacy Revenue in 2024
3.5 Global Key Players of Nuclear Pharmacy Head office and Area Served
3.6 Global Key Players of Nuclear Pharmacy, Product and Application
3.7 Global Key Players of Nuclear Pharmacy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Nuclear Pharmacy Breakdown Data by Type
4.1 Global Nuclear Pharmacy Historic Market Size by Type (2020-2025)
4.2 Global Nuclear Pharmacy Forecasted Market Size by Type (2026-2031)
5 Nuclear Pharmacy Breakdown Data by Application
5.1 Global Nuclear Pharmacy Historic Market Size by Application (2020-2025)
5.2 Global Nuclear Pharmacy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Nuclear Pharmacy Market Size (2020-2031)
6.2 North America Nuclear Pharmacy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Nuclear Pharmacy Market Size by Country (2020-2025)
6.4 North America Nuclear Pharmacy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nuclear Pharmacy Market Size (2020-2031)
7.2 Europe Nuclear Pharmacy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Nuclear Pharmacy Market Size by Country (2020-2025)
7.4 Europe Nuclear Pharmacy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nuclear Pharmacy Market Size (2020-2031)
8.2 Asia-Pacific Nuclear Pharmacy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Nuclear Pharmacy Market Size by Region (2020-2025)
8.4 Asia-Pacific Nuclear Pharmacy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nuclear Pharmacy Market Size (2020-2031)
9.2 Latin America Nuclear Pharmacy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Nuclear Pharmacy Market Size by Country (2020-2025)
9.4 Latin America Nuclear Pharmacy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nuclear Pharmacy Market Size (2020-2031)
10.2 Middle East & Africa Nuclear Pharmacy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Nuclear Pharmacy Market Size by Country (2020-2025)
10.4 Middle East & Africa Nuclear Pharmacy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 PharmaLogic
11.1.1 PharmaLogic Company Details
11.1.2 PharmaLogic Business Overview
11.1.3 PharmaLogic Nuclear Pharmacy Introduction
11.1.4 PharmaLogic Revenue in Nuclear Pharmacy Business (2020-2025)
11.1.5 PharmaLogic Recent Development
11.2 Nihon Medi-Physics
11.2.1 Nihon Medi-Physics Company Details
11.2.2 Nihon Medi-Physics Business Overview
11.2.3 Nihon Medi-Physics Nuclear Pharmacy Introduction
11.2.4 Nihon Medi-Physics Revenue in Nuclear Pharmacy Business (2020-2025)
11.2.5 Nihon Medi-Physics Recent Development
11.3 Yantai Dongcheng Biochemicals
11.3.1 Yantai Dongcheng Biochemicals Company Details
11.3.2 Yantai Dongcheng Biochemicals Business Overview
11.3.3 Yantai Dongcheng Biochemicals Nuclear Pharmacy Introduction
11.3.4 Yantai Dongcheng Biochemicals Revenue in Nuclear Pharmacy Business (2020-2025)
11.3.5 Yantai Dongcheng Biochemicals Recent Development
11.4 Curium Pharma
11.4.1 Curium Pharma Company Details
11.4.2 Curium Pharma Business Overview
11.4.3 Curium Pharma Nuclear Pharmacy Introduction
11.4.4 Curium Pharma Revenue in Nuclear Pharmacy Business (2020-2025)
11.4.5 Curium Pharma Recent Development
11.5 Cardinal Health
11.5.1 Cardinal Health Company Details
11.5.2 Cardinal Health Business Overview
11.5.3 Cardinal Health Nuclear Pharmacy Introduction
11.5.4 Cardinal Health Revenue in Nuclear Pharmacy Business (2020-2025)
11.5.5 Cardinal Health Recent Development
11.6 Jubilant Radiopharma
11.6.1 Jubilant Radiopharma Company Details
11.6.2 Jubilant Radiopharma Business Overview
11.6.3 Jubilant Radiopharma Nuclear Pharmacy Introduction
11.6.4 Jubilant Radiopharma Revenue in Nuclear Pharmacy Business (2020-2025)
11.6.5 Jubilant Radiopharma Recent Development
11.7 GE Healthcare
11.7.1 GE Healthcare Company Details
11.7.2 GE Healthcare Business Overview
11.7.3 GE Healthcare Nuclear Pharmacy Introduction
11.7.4 GE Healthcare Revenue in Nuclear Pharmacy Business (2020-2025)
11.7.5 GE Healthcare Recent Development
11.8 UPPI
11.8.1 UPPI Company Details
11.8.2 UPPI Business Overview
11.8.3 UPPI Nuclear Pharmacy Introduction
11.8.4 UPPI Revenue in Nuclear Pharmacy Business (2020-2025)
11.8.5 UPPI Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Nuclear Pharmacy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Diagnostic Products
Table 3. Key Players of Therapeutic Products
Table 4. Global Nuclear Pharmacy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Nuclear Pharmacy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Nuclear Pharmacy Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Nuclear Pharmacy Market Share by Region (2020-2025)
Table 8. Global Nuclear Pharmacy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Nuclear Pharmacy Market Share by Region (2026-2031)
Table 10. Nuclear Pharmacy Market Trends
Table 11. Nuclear Pharmacy Market Drivers
Table 12. Nuclear Pharmacy Market Challenges
Table 13. Nuclear Pharmacy Market Restraints
Table 14. Global Nuclear Pharmacy Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Nuclear Pharmacy Market Share by Players (2020-2025)
Table 16. Global Top Nuclear Pharmacy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Pharmacy as of 2024)
Table 17. Ranking of Global Top Nuclear Pharmacy Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Nuclear Pharmacy Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Nuclear Pharmacy, Headquarters and Area Served
Table 20. Global Key Players of Nuclear Pharmacy, Product and Application
Table 21. Global Key Players of Nuclear Pharmacy, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Nuclear Pharmacy Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Nuclear Pharmacy Revenue Market Share by Type (2020-2025)
Table 25. Global Nuclear Pharmacy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Nuclear Pharmacy Revenue Market Share by Type (2026-2031)
Table 27. Global Nuclear Pharmacy Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Nuclear Pharmacy Revenue Market Share by Application (2020-2025)
Table 29. Global Nuclear Pharmacy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Nuclear Pharmacy Revenue Market Share by Application (2026-2031)
Table 31. North America Nuclear Pharmacy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Nuclear Pharmacy Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Nuclear Pharmacy Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Nuclear Pharmacy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Nuclear Pharmacy Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Nuclear Pharmacy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Nuclear Pharmacy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Nuclear Pharmacy Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Nuclear Pharmacy Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Nuclear Pharmacy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Nuclear Pharmacy Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Nuclear Pharmacy Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Nuclear Pharmacy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Nuclear Pharmacy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Nuclear Pharmacy Market Size by Country (2026-2031) & (US$ Million)
Table 46. PharmaLogic Company Details
Table 47. PharmaLogic Business Overview
Table 48. PharmaLogic Nuclear Pharmacy Product
Table 49. PharmaLogic Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)
Table 50. PharmaLogic Recent Development
Table 51. Nihon Medi-Physics Company Details
Table 52. Nihon Medi-Physics Business Overview
Table 53. Nihon Medi-Physics Nuclear Pharmacy Product
Table 54. Nihon Medi-Physics Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)
Table 55. Nihon Medi-Physics Recent Development
Table 56. Yantai Dongcheng Biochemicals Company Details
Table 57. Yantai Dongcheng Biochemicals Business Overview
Table 58. Yantai Dongcheng Biochemicals Nuclear Pharmacy Product
Table 59. Yantai Dongcheng Biochemicals Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)
Table 60. Yantai Dongcheng Biochemicals Recent Development
Table 61. Curium Pharma Company Details
Table 62. Curium Pharma Business Overview
Table 63. Curium Pharma Nuclear Pharmacy Product
Table 64. Curium Pharma Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)
Table 65. Curium Pharma Recent Development
Table 66. Cardinal Health Company Details
Table 67. Cardinal Health Business Overview
Table 68. Cardinal Health Nuclear Pharmacy Product
Table 69. Cardinal Health Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)
Table 70. Cardinal Health Recent Development
Table 71. Jubilant Radiopharma Company Details
Table 72. Jubilant Radiopharma Business Overview
Table 73. Jubilant Radiopharma Nuclear Pharmacy Product
Table 74. Jubilant Radiopharma Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)
Table 75. Jubilant Radiopharma Recent Development
Table 76. GE Healthcare Company Details
Table 77. GE Healthcare Business Overview
Table 78. GE Healthcare Nuclear Pharmacy Product
Table 79. GE Healthcare Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)
Table 80. GE Healthcare Recent Development
Table 81. UPPI Company Details
Table 82. UPPI Business Overview
Table 83. UPPI Nuclear Pharmacy Product
Table 84. UPPI Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)
Table 85. UPPI Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
Table 89. Authors List of This Report
List of Figures
Figure 1. Nuclear Pharmacy Picture
Figure 2. Global Nuclear Pharmacy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Nuclear Pharmacy Market Share by Type: 2024 VS 2031
Figure 4. Diagnostic Products Features
Figure 5. Therapeutic Products Features
Figure 6. Global Nuclear Pharmacy Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Nuclear Pharmacy Market Share by Application: 2024 VS 2031
Figure 8. Pharmaceutical Case Studies
Figure 9. Hospital Case Studies
Figure 10. Laboratory Case Studies
Figure 11. Nuclear Pharmacy Report Years Considered
Figure 12. Global Nuclear Pharmacy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Nuclear Pharmacy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Nuclear Pharmacy Market Share by Region: 2024 VS 2031
Figure 15. Global Nuclear Pharmacy Market Share by Players in 2024
Figure 16. Global Top Nuclear Pharmacy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Pharmacy as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Nuclear Pharmacy Revenue in 2024
Figure 18. North America Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Nuclear Pharmacy Market Share by Country (2020-2031)
Figure 20. United States Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Nuclear Pharmacy Market Share by Country (2020-2031)
Figure 24. Germany Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Nuclear Pharmacy Market Share by Region (2020-2031)
Figure 32. China Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Nuclear Pharmacy Market Share by Country (2020-2031)
Figure 40. Mexico Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Nuclear Pharmacy Market Share by Country (2020-2031)
Figure 44. Turkey Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. PharmaLogic Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)
Figure 48. Nihon Medi-Physics Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)
Figure 49. Yantai Dongcheng Biochemicals Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)
Figure 50. Curium Pharma Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)
Figure 51. Cardinal Health Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)
Figure 52. Jubilant Radiopharma Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)
Figure 53. GE Healthcare Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)
Figure 54. UPPI Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Table 1. Global Nuclear Pharmacy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Diagnostic Products
Table 3. Key Players of Therapeutic Products
Table 4. Global Nuclear Pharmacy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Nuclear Pharmacy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Nuclear Pharmacy Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Nuclear Pharmacy Market Share by Region (2020-2025)
Table 8. Global Nuclear Pharmacy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Nuclear Pharmacy Market Share by Region (2026-2031)
Table 10. Nuclear Pharmacy Market Trends
Table 11. Nuclear Pharmacy Market Drivers
Table 12. Nuclear Pharmacy Market Challenges
Table 13. Nuclear Pharmacy Market Restraints
Table 14. Global Nuclear Pharmacy Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Nuclear Pharmacy Market Share by Players (2020-2025)
Table 16. Global Top Nuclear Pharmacy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Pharmacy as of 2024)
Table 17. Ranking of Global Top Nuclear Pharmacy Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Nuclear Pharmacy Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Nuclear Pharmacy, Headquarters and Area Served
Table 20. Global Key Players of Nuclear Pharmacy, Product and Application
Table 21. Global Key Players of Nuclear Pharmacy, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Nuclear Pharmacy Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Nuclear Pharmacy Revenue Market Share by Type (2020-2025)
Table 25. Global Nuclear Pharmacy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Nuclear Pharmacy Revenue Market Share by Type (2026-2031)
Table 27. Global Nuclear Pharmacy Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Nuclear Pharmacy Revenue Market Share by Application (2020-2025)
Table 29. Global Nuclear Pharmacy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Nuclear Pharmacy Revenue Market Share by Application (2026-2031)
Table 31. North America Nuclear Pharmacy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Nuclear Pharmacy Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Nuclear Pharmacy Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Nuclear Pharmacy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Nuclear Pharmacy Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Nuclear Pharmacy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Nuclear Pharmacy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Nuclear Pharmacy Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Nuclear Pharmacy Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Nuclear Pharmacy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Nuclear Pharmacy Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Nuclear Pharmacy Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Nuclear Pharmacy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Nuclear Pharmacy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Nuclear Pharmacy Market Size by Country (2026-2031) & (US$ Million)
Table 46. PharmaLogic Company Details
Table 47. PharmaLogic Business Overview
Table 48. PharmaLogic Nuclear Pharmacy Product
Table 49. PharmaLogic Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)
Table 50. PharmaLogic Recent Development
Table 51. Nihon Medi-Physics Company Details
Table 52. Nihon Medi-Physics Business Overview
Table 53. Nihon Medi-Physics Nuclear Pharmacy Product
Table 54. Nihon Medi-Physics Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)
Table 55. Nihon Medi-Physics Recent Development
Table 56. Yantai Dongcheng Biochemicals Company Details
Table 57. Yantai Dongcheng Biochemicals Business Overview
Table 58. Yantai Dongcheng Biochemicals Nuclear Pharmacy Product
Table 59. Yantai Dongcheng Biochemicals Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)
Table 60. Yantai Dongcheng Biochemicals Recent Development
Table 61. Curium Pharma Company Details
Table 62. Curium Pharma Business Overview
Table 63. Curium Pharma Nuclear Pharmacy Product
Table 64. Curium Pharma Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)
Table 65. Curium Pharma Recent Development
Table 66. Cardinal Health Company Details
Table 67. Cardinal Health Business Overview
Table 68. Cardinal Health Nuclear Pharmacy Product
Table 69. Cardinal Health Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)
Table 70. Cardinal Health Recent Development
Table 71. Jubilant Radiopharma Company Details
Table 72. Jubilant Radiopharma Business Overview
Table 73. Jubilant Radiopharma Nuclear Pharmacy Product
Table 74. Jubilant Radiopharma Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)
Table 75. Jubilant Radiopharma Recent Development
Table 76. GE Healthcare Company Details
Table 77. GE Healthcare Business Overview
Table 78. GE Healthcare Nuclear Pharmacy Product
Table 79. GE Healthcare Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)
Table 80. GE Healthcare Recent Development
Table 81. UPPI Company Details
Table 82. UPPI Business Overview
Table 83. UPPI Nuclear Pharmacy Product
Table 84. UPPI Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)
Table 85. UPPI Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
Table 89. Authors List of This Report
List of Figures
Figure 1. Nuclear Pharmacy Picture
Figure 2. Global Nuclear Pharmacy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Nuclear Pharmacy Market Share by Type: 2024 VS 2031
Figure 4. Diagnostic Products Features
Figure 5. Therapeutic Products Features
Figure 6. Global Nuclear Pharmacy Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Nuclear Pharmacy Market Share by Application: 2024 VS 2031
Figure 8. Pharmaceutical Case Studies
Figure 9. Hospital Case Studies
Figure 10. Laboratory Case Studies
Figure 11. Nuclear Pharmacy Report Years Considered
Figure 12. Global Nuclear Pharmacy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Nuclear Pharmacy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Nuclear Pharmacy Market Share by Region: 2024 VS 2031
Figure 15. Global Nuclear Pharmacy Market Share by Players in 2024
Figure 16. Global Top Nuclear Pharmacy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Pharmacy as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Nuclear Pharmacy Revenue in 2024
Figure 18. North America Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Nuclear Pharmacy Market Share by Country (2020-2031)
Figure 20. United States Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Nuclear Pharmacy Market Share by Country (2020-2031)
Figure 24. Germany Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Nuclear Pharmacy Market Share by Region (2020-2031)
Figure 32. China Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Nuclear Pharmacy Market Share by Country (2020-2031)
Figure 40. Mexico Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Nuclear Pharmacy Market Share by Country (2020-2031)
Figure 44. Turkey Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. PharmaLogic Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)
Figure 48. Nihon Medi-Physics Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)
Figure 49. Yantai Dongcheng Biochemicals Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)
Figure 50. Curium Pharma Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)
Figure 51. Cardinal Health Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)
Figure 52. Jubilant Radiopharma Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)
Figure 53. GE Healthcare Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)
Figure 54. UPPI Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232